Both Health Canada and the FDA today, have only approved FMT for the treatment of C. difficile. However, there are several additional conditions that show compelling research including autism, IBD (Crohn’s, ulcerative colitis), IBS and chronic fatigue. There may be a role for FMT in patients with chronic constipation and neurodegenerative disease including Parkinson’s and multiple sclerosis.

Yes, we do accept patients outside of the set retreat dates who have conditions that are likely to benefit from FMT. If you want to be considered for FMT treatment for your particular condition, please send an email and we will get back to you shortly to set up a call if appropriate.

Yes, many of our patients come via referral or on the suggestion of their health care providers at home. We welcome referrals and collaboration so please send an email and we would be happy to set up a call and support you in educating your patients.

You will first have to speak with the medical team who will help you in deciding if you are, or your child is an appropriate fit for this progressive therapy. Once qualified, and to reserve a treatment spot in our program, we require a payment of $5,000 USD deposit to secure your spot for a set date.

The youngest children we accept are 3 years old, with no upper limit on age, meaning, we work with adult children with autism as well.

We currently accept 15 – 20 children per retreat, per location, to ensure the highest standard of care.

We ensure a consistent high standard of care across all locations. Choice is often based on preference, travel distance or in some cases, timing and availability on given dates.

Although past families may go public with regard to their treatment results and experience in working with Novel Biome, we do not facilitate conversations between past patients and inquiring attendees as we take patient privacy very seriously. We have been made aware of an independently formed parent advocacy group who have asked us to help make other parents aware of their existence. To this end, we have included a “ Parent Advocacy Tab” in the top section of our home page. Please visit and view the many parent testimonials included within our site

Yes, we are happy to speak with your referring physician to answer any questions they may have as well as to collaborate on the best pre-FMT treatment strategy.

Yes, Jason Klop advises the location licensed staff members throughout the retreat and is always accessible to answer any of your questions.

Some have hypothesized that age- and gender-matched donors may be advantageous, although currently there is no data to support this hypothesis. We constantly study data to optimize donor matching. Please visit our “donor screening” information within our site

Yes, we are committed to ensuring you are able to complete the full 16 weeks of treatment without incident and will support you in collaboration with your medical team at home.

We don’t have enough data to suggest whether or not this is helpful or necessary in regards to FMT for the treatment of autism. With that said, Jason Klop does not believe repeat FMT treatments are necessary in the majority of cases. Where there may be an exception is if your child had to go on a strong and prolonged course of antibiotics and you saw a regression in their improvement since treatment.

In some cases, improvements can be observed during the first week of treatment. However, as a rule of thumb, most children begin showing improvements in digestive symptoms at 5 weeks and improvement in autism-related symptoms at 8 weeks.

Some children experience mild to moderate hyperactivity and tantrums or aggression during the pre-FMT treatment.

Each attendee will receive a minimum of 2 donors throughout the course of treatment. This is similar to the protocol by Dr. Adams at Arizona State University. Please view our data on Donor Screening.

In preparation for FMT, we suggest individualized pre-treatment prescriptions including proton pump inhibitors (PPI’s) and antibiotics to be prescribed by your doctor or a doctor we suggest. In the case of PPI’s, studies have shown that some people treated with PPI’s have different types of bacteria in their gut compared to untreated patients, indicating an increased risk of GI infection when on PPI’s.

We seek to be totally transparent in what we do. To this end, we encourage everyone to investigate and research in order to make an informed treatment decision that is best for them.  As an example, please see this publicly available, third party, independent overview of FMT for your review.